PMC:7461420 / 17632-17860 JSONTXT

{"project":"LitCovid-PD-MONDO","denotations":[{"id":"T100","span":{"begin":90,"end":94},"obj":"Disease"}],"attributes":[{"id":"A100","pred":"mondo_id","subj":"T100","obj":"http://purl.obolibrary.org/obo/MONDO_0005091"}],"text":"d the oxazole‐carboxamide derivative SSAA09E2 (1; Figure 4) as an entry inhibitor against SARS‐CoV‐1 by screening a chemical library composed of 3000 compounds. 47 This inhibitor directly blocks ACE2 recognition by interfering "}

{"project":"LitCovid-PD-CLO","denotations":[{"id":"T201","span":{"begin":114,"end":115},"obj":"http://purl.obolibrary.org/obo/CLO_0001020"}],"text":"d the oxazole‐carboxamide derivative SSAA09E2 (1; Figure 4) as an entry inhibitor against SARS‐CoV‐1 by screening a chemical library composed of 3000 compounds. 47 This inhibitor directly blocks ACE2 recognition by interfering "}

{"project":"LitCovid-PD-CHEBI","denotations":[{"id":"T129","span":{"begin":6,"end":13},"obj":"Chemical"},{"id":"T131","span":{"begin":14,"end":25},"obj":"Chemical"},{"id":"T133","span":{"begin":72,"end":81},"obj":"Chemical"},{"id":"T134","span":{"begin":170,"end":179},"obj":"Chemical"}],"attributes":[{"id":"A129","pred":"chebi_id","subj":"T129","obj":"http://purl.obolibrary.org/obo/CHEBI_35597"},{"id":"A130","pred":"chebi_id","subj":"T129","obj":"http://purl.obolibrary.org/obo/CHEBI_35790"},{"id":"A131","pred":"chebi_id","subj":"T131","obj":"http://purl.obolibrary.org/obo/CHEBI_23004"},{"id":"A132","pred":"chebi_id","subj":"T131","obj":"http://purl.obolibrary.org/obo/CHEBI_37622"},{"id":"A133","pred":"chebi_id","subj":"T133","obj":"http://purl.obolibrary.org/obo/CHEBI_35222"},{"id":"A134","pred":"chebi_id","subj":"T134","obj":"http://purl.obolibrary.org/obo/CHEBI_35222"}],"text":"d the oxazole‐carboxamide derivative SSAA09E2 (1; Figure 4) as an entry inhibitor against SARS‐CoV‐1 by screening a chemical library composed of 3000 compounds. 47 This inhibitor directly blocks ACE2 recognition by interfering "}

{"project":"LitCovid-PubTator","denotations":[{"id":"576","span":{"begin":196,"end":200},"obj":"Gene"},{"id":"578","span":{"begin":90,"end":98},"obj":"Species"},{"id":"579","span":{"begin":6,"end":25},"obj":"Chemical"}],"attributes":[{"id":"A576","pred":"tao:has_database_id","subj":"576","obj":"Gene:59272"},{"id":"A578","pred":"tao:has_database_id","subj":"578","obj":"Tax:694009"}],"namespaces":[{"prefix":"Tax","uri":"https://www.ncbi.nlm.nih.gov/taxonomy/"},{"prefix":"MESH","uri":"https://id.nlm.nih.gov/mesh/"},{"prefix":"Gene","uri":"https://www.ncbi.nlm.nih.gov/gene/"},{"prefix":"CVCL","uri":"https://web.expasy.org/cellosaurus/CVCL_"}],"text":"d the oxazole‐carboxamide derivative SSAA09E2 (1; Figure 4) as an entry inhibitor against SARS‐CoV‐1 by screening a chemical library composed of 3000 compounds. 47 This inhibitor directly blocks ACE2 recognition by interfering "}